The projections suggest that high but achievable coverage levels of NSPs can result in large decreases in HIV incidence in settings where HIV prevalence is high among people who inject drugs.
Dogmatic positions on harsher prohibition and blanket decriminalisation fail to reflect the impacts that such policies will have on drug-producing countries.